Metastatic RCC: Prognosis and Recent Advances in Care
Mehmet Asim Bilen, MD comments on the prognosis of patients with metastatic RCC and how recent advances have improved outcomes.
Recent Videos
Related Content
Hereditary Renal Tumor Syndromes and the Use of mTOR Inhibitors
José Luis Rodríguez-Olivares, MD;Héctor Raúl González-Sánchez, MD;Evelyn Lilian Beas-Lozano, MD;Jazmin Arteaga-Vázquez, MD;Elaine T. Lam, MD;María T. Bourlon, MD, MSc, FASCO
October 22nd 2024Article
A 47-year-old woman with a history of drug-resistant epilepsy during childhood presented to the emergency department with sudden dyspnea and chest pain. Upon admission, her oxygen saturation was 88%.
